Dr. Ofra Levy-Hacham

Dr. Ofra Levy-Hacham has served as Sol-Gel’s Vice President of Clinical and Regulatory Affairs since 2018, and as our Vice President of Quality and Regulatory Affairs from 2011 to 2018.

Prior to joining Sol-Gel, Dr. Levy-Hacham served as a scientific specialist and project manager at Biotechnology General Ltd., a wholly owned subsidiary of Ferring Pharmaceuticals Ltd., and a fully integrated biopharmaceutical services private company from 2010 until 2011.

From 2005 until 2010, Dr. Levy-Hacham served as Vice President of Chemistry, Manufacturing and Controls at HealOr Ltd., a private company engaging in the development of therapeutics for the treatment of various skin disorders.

Dr. Levy-Hacham holds a PhD in chemistry from The Technion – Israel Institute of Technology, Israel.